首页|微小核糖核酸-155对肝癌细胞增殖、侵袭迁移和凋亡的影响

微小核糖核酸-155对肝癌细胞增殖、侵袭迁移和凋亡的影响

The effect of microRNA-155 on the proliferation,invasion,migration and apoptosis of hepatocellular carcinoma cells

扫码查看
目的 探究微小核糖核酸(miR)-155 靶向蛋白酪氨酸磷酸酶非受体 21 型(PTPN21)调控磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶B(AKT)信号通路对肝癌细胞增殖、迁移、侵袭的影响.方法 体外培养Huh7 人肝癌细胞并通过miR-155 沉默慢病毒(sh-miR-155)转染下调miR-155.实时荧光定量聚合酶链反应(RT-qPCR)检测Huh7 细胞miR-155 沉默效果,获得稳转细胞株后将细胞株随机分为:Blank 组(正常Huh7 细胞)、shNC组(Huh7 细胞+miR-155 空载体)、sh-miR-155 组(Huh7 细胞+miR-155 沉默)、sh-miR-155+Recilisib组(Huh7 细胞+miR-155 沉默+PI3K-AKT激动剂)、shNC+Recilisib 组(Huh7 细胞+miR-155 空载体+PI3K-AKT激动剂).双荧光素酶实验检测PTPN21 是否为miR-155 的下游;溴化噻唑蓝四氮唑(MTT)法检测各组细胞增殖能力;流式细胞术测定各组细胞凋亡水平;Transwell实验分析各组细胞侵袭与迁移能力;蛋白质印迹检测各组PTPN21、通路相关蛋白PI3K、P-PI3K、AKT、P-AKT及凋亡相关蛋白BAX、BCL-2、Caspase-3 表达变化差异.结果 sh-miR-155 组中miR-155 的表达水平低于Blank组及shNC组(P<0.000 1),miR-155 在Blank组及shNC组表达水平差异无统计学意义(P>0.05).MTT结果显示,sh-miR-155 组中Huh7 细胞在 2、3、4、5 d时A值均低于Blank组及shNC组(P<0.000 1),而Blank组与shNC组差异无统计学意义(P>0.05);sh-miR-155 组在 2、3、4、5 d时A值低于sh-miR-155+Recilisib组及shNC+Recilisib组(P=0.005 2,P<0.000 1),而sh-miR-155+Recilisib组在 2、3、4、5 d时A值低于shNC+Recilisib组(P<0.0001).Blank组与shNC组迁移及侵袭细胞数差异无统计学意义(P>0.05),激活PI3K-AKT信号通路后,与Blank组相比,shNC+Recilisib组肝癌细胞的迁移、侵袭能力显著增加(P<0.0001).相反,沉默miR-155 后Huh7 细胞的迁移及侵袭细胞数明显低于Blank组及shNC组(P<0.000 1),而PI3K激动剂逆转了这一现象,与sh-miR-155 组相比,sh-miR-155+Recilisib组肝癌细胞的迁移、侵袭能力增强(P=0.000 2).慢病毒转染Huh7 人肝癌细胞以沉默miR-155,下调miR-155 抑制PTPN21 调控PI3K-AKT信号通路从而抑制肝癌细胞的侵袭、迁移、增殖能力,促进肝癌细胞凋亡.结论 miR-155 通过靶向PTPN21 调控PI3K-AKT信号通路抑制肝癌细胞的迁移、侵袭、增殖.miR-155 可能是未来肝癌治疗潜在靶点.
Objective To discuss the effect of PI3K-AKT signaling pathway regulated by microRNA-155(miRNA-155)targeted protein tyrosine phosphatase non-receptor type 21(PTPN21)on the proliferation,migration and invasion of hepatocellular carcinoma(HCC)cells.Methods Lentivirus transfection was used to silence the expression of miRNA-155 in human Huh7 HCC cells,and real-time fluorescent quantitative polymerase chain reaction(RT-qPCR)was used to detect the silencing effect of miR-155.After obtaining stable cell lines,the cell lines were randomly divided into Blank group(normal Huh7 cells),shNC group(Huh7 cells+empty miR-155 vector),sh-miR-155(Huh7 cells+miR-155 silencing),sh-miR-155+Recilisib group(Huh7 cells+miR-155 silencing+PI3K-AKT agonist),shNC+Recilisib group(Huh7 cells+empty miR-155 vector+PI3K-AKT agonist).Dual luciferase assay was used to determine whether PTPN21 was the downstream of miR-155.The cell proliferation ability of cells in each group was detected by MTT assay.The apoptosis level of each group was tested by flow cytometry.The invasion and migration ability of cells was assessed by Transwell assay.Western blot analysis was used to observe the differences in protein expression of PTPN21,PI3K,P-PI3K,AKT,P-AKT,and apoptosis-related proteins including BAX,BCL-2 and caspase-3 in all groups.Results The expression level of miR-155 in sh-miR-155 group was lower than that in Blank group and shNC group(P<0.000 1),and the difference in miR-155 expression level between Blank group and shNC group was not statistically significant(P>0.05).MTT results showed that A values of Huh7 cells at 2,3,4 and 5 day in sh-miR-155 group were lower than those in Blank group and shNC group(P<0.000 1),while these differences between Blank group and shNC group were not statistically significant(P>0.05).In sh-miR-155 group the A values at 2,3,4 and 5 day were lower than those in sh-miR-155+Recilisib group and shNC+Recilisib group(P=0.0052 and P<0.0001,respectively),while the A values at 2,3,4 and 5 day in sh-miR-155+Recilisib were lower than those in shNC+Recilisib group(P<0.000 1).There was no significant differences in cell migration and number of invasion cells between the Blank group and shNC group(P>0.05).After activation of PI3K-AKT signaling pathway,the migration and invasion capacity of HCC cells in the shNC+Recilisib group were significantly enhanced when compared with the Blank group(P<0.000 1).In contrast,the number of migrated and invaded Huh7 cells after miR-155 silencing was significantly lower than that in the Blank group and shNC group(P<0.000 1)and this phenomenon became reversed by PI3K agonist.Compared with the sh-miR-155 group,in the sh-miR-155+Recilisib group the migration and invasion ability of HCC cells was enhanced(P=0.000 2).Lentiviral transfection of Huh7 human HCC cells to silence miR-155 and downregulate miR-155 inhibiting PTPN21 regulation of the PI3K-AKT signaling pathway,thus inhibiting the invasion,migration and proliferation ability of HCC cells and promoting the apoptosis of HCC cells.Conclusion miR-155 inhibits the migration,invasion and proliferation of HCC cells through targeting PTPN21 regulation of PI3K-AKT signaling pathway.The miR-155 may be a potential therapeutic target for HCC in the future.(J Intervent Radiol,2024,32:44-51)

hepatocellular carcinomamicroRNA-155protein tyrosine phosphatase non-receptor type 21phosphatidylinositol 3-kinaseprotein kinase B

秦焕蓉、吴祥锴、江哲宇、张赟、林丽云、王黎洲、周石

展开 >

550004 贵州贵阳贵州医科大学影像学院

织金县医院

贵州医科大学附属医院介入科

肝癌 微小核糖核酸-155 蛋白酪氨酸磷酸酶非受体21型 磷脂酰肌醇3-激酶 蛋白激酶B

国家自然科学基金2022年贵州省卫生健康委省级医学重点学科建设项目

82060333

2024

介入放射学杂志
上海市医学会

介入放射学杂志

CSTPCD北大核心
影响因子:1.866
ISSN:1008-794X
年,卷(期):2024.33(1)
  • 3